Seres Therapeutics Inc - Trending symbols
Notifications
Type | Notification | Date |
---|---|---|
RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-04-17 |
Trends
2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Total Other Income Expense Net | -1,722 | -1,243 | -2,965 | 1,440 | -1,525 | -20,340 | -21,865 | 35,063 | 13,198 | |
Net Working Capital | 76,751 | -10,048 | 66,703 | -25,720 | 40,983 | -32,888 | 8,095 | -10,643 | -2,548 | |
Total Stockholder Equity | -15,123 | -29,733 | -44,856 | -14,882 | -59,738 | -27,336 | -87,074 | 110,993 | 23,919 | |
Net Income | -47,854 | 6,606 | -41,248 | 1,115 | -40,133 | 7,263 | -32,870 | 121,646 | 88,776 | |
Net Interest Income | -1,440 | -618 | -2,058 | -957 | -3,015 | 798 | -2,217 | 2,869 | 652 | |
Income before Tax | -47,854 | 6,606 | -41,248 | 1,115 | -40,133 | 7,263 | -32,870 | 121,646 | 88,776 | |
EBIT | -63,325 | 4,218 | -59,107 | -9,200 | -68,307 | -2,261 | -70,568 | 118,780 | 48,212 | |
EBITDA | -61,549 | 5,021 | -56,528 | -8,761 | -65,289 | -2,537 | -67,826 | 117,565 | 49,739 | |
Operating Income | -63,325 | 4,218 | -59,107 | -9,200 | -68,307 | -2,261 | -70,568 | 120,092 | 49,524 | |
Net Income from Continuing Operations | -64,735 | 4,733 | -60,002 | -8,794 | -68,796 | -2,378 | -71,174 | 117,726 | 46,552 | |
Net Debt | -75,560 | 25,942 | -49,618 | -79,740 | -129,358 | 128,918 | -440 | 68,309 | 67,869 | |
Net Tangible Assets | 80,956 | -57,898 | 23,058 | 44,527 | 67,585 | -56,802 | 10,783 | -58,654 | -47,871 | |
Accumulated Other Comprehensive Income | -215 | -41 | -256 | 138 | -118 | 106 | -12 | 14 | 2 | |
Total Revenue | 1,493 | -277 | 1,216 | 2,228 | 3,444 | -2,469 | 975 | -1,497 | -522 | |
Gross Profit | 7,221 | -5,728 | 1,493 | -548 | 945 | 1,448 | 2,393 | -2,422 | -29 | |
Other Stockholders Equity | 727,869 | 5,664 | 733,533 | 6,455 | 739,988 | 5,841 | 745,829 | -746,044 | -215 | |
Other Operating Expenses | 35,462 | 5,582 | 41,044 | 12,361 | 53,405 | 4,913 | 58,318 | -58,923 | -605 | |
Interest Expense | 759 | -63 | 696 | 36 | 732 | 12 | 744 | -5,826 | -5,082 |
Comments
How you think about this?